Evolent Health Announces Second Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Evolent Health (EVH) PT Lowered to $33 at Cowen; Reiterates Outperform
August 8, 2017 7:42 AM EDTCowen lowered its price target on Evolent Health (NYSE: EVH) to $33.00 (from $35.00) while maintaining a Outperform rating following 2Q release. Reported revenues of $107.3M exceeded guidance, and consensus estimates, despite soft transformation sales. Adjusted EPS of ($0.13) was in-line with Street's expectations.
EVH... More
Evolent Health (EVH) Reports In-Line Q2 EPS
August 7, 2017 4:02 PM EDTEvolent Health (NYSE: EVH) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $107.3 million versus the consensus estimate of $104.45 million.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
... More